Growth Metrics

Nexalin Technology (NXL) EBITDA Margin (2021 - 2026)

Nexalin Technology's quarterly EBITDA Margin came in at 14025.08% in Q1 2026, down 917927.0% year-on-year from N/an in Q1 2025, and down 914.87% quarter-over-quarter from 1381.95% in Q4 2025.

Nexalin Technology has reported EBITDA Margin for 6 years, with the latest figure at 14025.08% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 917927.0% year-over-year to 14025.08%; the trailing twelve-month figure through Mar 2026 stood at 3022.88% (up 350350.0% YoY), and the FY2025 full-year result was 2725.46%, up 178334.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 14025.08%, down from 1381.95% in the prior quarter.
  • The five-year high for EBITDA Margin was 24.83% in Q3 2022, with the low at 14025.08% in Q1 2026.
  • Average EBITDA Margin over 5 years is 4620.77%, with a median of 2336.57% recorded in 2023.
  • Year-over-year, EBITDA Margin slumped 963584 bps in 2023 and jumped 904324 bps in 2025.
  • Tracing NXL's EBITDA Margin over 5 years: stood at 1804.51% in 2022, then tumbled by 111 bps to 3807.33% in 2023, then tumbled by 174 bps to 10425.19% in 2024, then surged by 87 bps to 1381.95% in 2025, then tumbled by 915 bps to 14025.08% in 2026.
  • The last three EBITDA Margin figures came in at 14025.08% (Q1 2026), 1381.95% (Q4 2025), and 12550.4% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -14,025.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14,025.08%
Dec 31, 2025 -1,381.95%
Sep 30, 2025 -12,550.40%
Jun 30, 2025 -2,239.01%
Mar 31, 2025 -4,845.81%
Dec 31, 2024 -10,425.19%
Sep 30, 2024 -6,795.76%
Jun 30, 2024 -4,784.83%
Mar 31, 2024 -1,323.23%
Dec 31, 2023 -3,807.33%
Sep 30, 2023 -9,660.67%
Jun 30, 2023 -2,336.57%
Mar 31, 2023 -2,314.61%
Dec 31, 2022 -1,804.51%
Sep 30, 2022 -24.83%
Jun 30, 2022 -111.61%
Mar 31, 2022 -121.63%
Dec 31, 2021 -2,406.30%
Sep 30, 2021 -3,207.88%